A former sales executive of a Boston laboratory who lives in Mars is among more than a dozen healthcare executives named in a Justice Department whistleblower lawsuit alleging that they engaged in a wide-ranging kickback scheme in Texas involving hospitals and labs.

Matthew Theiler, former vice president of sales in Texas for Massachusetts-based Boston Heart Diagnostics Corp., (BHD) is accused of playing a role in the scheme as supervisor of lab employees responsible for sales in Texas.

The suit, filed in the Eastern District of Texas, names the chief executive of BHD and the CEO of another lab, a hospital CEO and numerous other people and entities, all accused of violating the False Claims Act based on patient referrals and claims of improper billing to federal healthcare programs for lab testing.

The complaint says that BHD and another lab, True Health Diagnostics, conspired with small Texas hospitals, including Rockdale Hospital, to pay doctors to induce referrals to the hospitals for testing by the two labs.

Advertise with us

The hospitals paid a portion of their lab profits to recruiters, who then kicked back those funds to the referring doctors, according to the complaint.

The recruiters set up companies called management service organizations to make payments to the doctors and disguise them as investment returns, the Justice Department said.

Government lawyers said executives of the two labs and their sales forces, including Mr. Theiler, leveraged the management service organization kickbacks to doctors to increase referrals and in turn their own bonuses and commissions.

The lab tests were billed to federal healthcare programs such as Medicare. In many cases, the complaint said, the tests were not "reasonable and necessary," DOJ said.

The lawsuit says the defendants violated the Anti-Kickback statute, which prohibits paying for referrals for services covered by Medicare, and the Stark Law, which forbids a hospital or lab from billing Medicare for services referred by doctors who have a financial relationship with the hospital or lab.

Advertise with us

Both laws are designed to make sure medical providers are acting in the best interest of patients and not their own financial gain, the Justice Department said.

All of the defendants are from Texas except Mr. Theiler and Susan Hertzberg, BHD's former CEO, who is from New York.

The original whistleblower lawsuit was filed in federal court in Los Angeles in 2016. The Justice Department filed notice last year that it would intervene under the whistleblower provisions of the False Claims Act, which allows a private party to file a civil action on behalf of the U.S. government and receive part of any damages.

The act allows the U.S. to intervene and add defendants, which it did in this case.